Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer.
Sumodhee S, Guo L, Bouhlel L, Picard A, Otto J, Naghavi AO, Richier Q, Lévy A, Bondiau PY, Poudenx M, Passeron T, Lacour JP, Montaudié H, Doyen J. Sumodhee S, et al. Among authors: doyen j. Cancer Radiother. 2022 Nov;26(8):1045-1053. doi: 10.1016/j.canrad.2022.04.005. Epub 2022 Aug 1. Cancer Radiother. 2022. PMID: 35927166
Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy.
Toussaint L, Matysiak W, Alapetite C, Aristu J, Bannink-Gawryszuk A, Bolle S, Bolsi A, Calvo F, Cerron Campoo F, Charlwood F, Demoor-Goldschmidt C, Doyen J, Drosik-Rutowicz K, Dutheil P, Embring A, Engellau J, Goedgebeur A, Goudjil F, Harrabi S, Kopec R, Kristensen I, Lægsdmand P, Lütgendorf-Caucig C, Meijers A, Mirandola A, Missohou F, Montero Feijoo M, Muren LP, Ondrova B, Orlandi E, Pettersson E, Pica A, Plaude S, Righetto R, Rombi B, Timmermann B, Van Beek K, Vela A, Vennarini S, Vestergaard A, Vidal M, Vondracek V, Weber DC, Whitfield G, Zimmerman J, Maduro JH, Lassen-Ramshad Y. Toussaint L, et al. Among authors: doyen j. Radiother Oncol. 2024 Sep;198:110414. doi: 10.1016/j.radonc.2024.110414. Epub 2024 Jun 26. Radiother Oncol. 2024. PMID: 38942120 Free article.
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
Mortensen HR, Populaire P, Hoffmann L, Moeller DS, Appelt A, Nafteux P, Muijs CT, Grau C, Hawkins MA, Troost EGC, Defraene G, Canters R, Clarke CS, Weber DC, Korevaar EW, Haustermans K, Nordsmark M, Gebski V, Achiam MP, Markar SR, Radhakrishna G, Berbee M, Scartoni D, Orlandi E, Doyen J, Gregoire V, Crehange G, Langendijk J, Lorgelly P, Blommenstein HM, Byskov CS, Ehmsen ML, Jensen MF, Freixas GV, Bütof R; PROTECT consortium. Mortensen HR, et al. Among authors: doyen j. Radiother Oncol. 2024 Jan;190:109980. doi: 10.1016/j.radonc.2023.109980. Epub 2023 Nov 5. Radiother Oncol. 2024. PMID: 37935284 Free article. No abstract available.
Patients' needs in proton therapy: A survey among ten European facilities.
Mazzola GC, Bergamaschi L, Pedone C, Vincini MG, Pepa M, Zaffaroni M, Volpe S, Rombi B, Doyen J, Fossati P, Haustermans K, Høyer M, Langendijk JA, Matute R, Orlandi E, Rylander H, Troost EGC, Orecchia R, Alterio D, Jereczek-Fossa BA. Mazzola GC, et al. Among authors: doyen j. Clin Transl Radiat Oncol. 2023 Aug 22;43:100670. doi: 10.1016/j.ctro.2023.100670. eCollection 2023 Nov. Clin Transl Radiat Oncol. 2023. PMID: 37736140 Free PMC article.
[Spinals and paraspinals tumors treated by CyberKnife: feasibility and efficacy].
Castelli J, Thariat J, Benezery K, Courdi A, Chanalet S, Paquis P, Doyen J, Frenay M, Mammar H, Bondiau PY. Castelli J, et al. Among authors: doyen j. Cancer Radiother. 2010 Jan;14(1):5-10. doi: 10.1016/j.canrad.2009.09.005. Epub 2009 Dec 14. Cancer Radiother. 2010. PMID: 20005764 French.
[Reirradiation of spine and lung tumor with CyberKnife].
Bondiau PY, Doyen J, Mammar H, Thariat J, Castelli J, Benezery K, Rucka G. Bondiau PY, et al. Among authors: doyen j. Cancer Radiother. 2010 Oct;14(6-7):438-41. doi: 10.1016/j.canrad.2010.06.011. Epub 2010 Aug 19. Cancer Radiother. 2010. PMID: 20724188 French.
Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.
Gérard JP, Baulieux J, Doyen J, Gal J, Letouze E, Olschwang S, Chapet O, Romestaing P. Gérard JP, et al. Among authors: doyen j. Cancer Radiother. 2012 Dec;16(8):688-96. doi: 10.1016/j.canrad.2012.09.003. Epub 2012 Nov 13. Cancer Radiother. 2012. PMID: 23153504
143 results